Pagnon de la Vega M, Syvänen S, Giedraitis V, Hooley M, Konstantinidis E, Meier SR, Rokka J, Eriksson J, Aguilar X, Spires-Jones TL, Lannfelt L, Nilsson LNG, Erlandsson A, Hultqvist G, Ingelsson M, Sehlin D(2024) Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion Acta Neuropathol Commun, 12(1), 22 DOI 10.1186/s40478-024-01734-x, PubMed 38317196
Zielinski M, Peralta Reyes FS, Gremer L, Schemmert S, Frieg B, Schäfer LU, Willuweit A, Donner L, Elvers M, Nilsson LNG, Syvänen S, Sehlin D, Ingelsson M, Willbold D, Schröder GF(2023) Cryo-EM of Aβ fibrils from mouse models find tg-APPArcSwe fibrils resemble those found in patients with sporadic Alzheimer's disease Nat Neurosci, 26(12), 2073-2080 DOI 10.1038/s41593-023-01484-4, PubMed 37973869
Sulheim E, WiderØe M, Bäck M, Nilsson KPR, Hammarström P, Nilsson LNG, Davies CL, Åslund AKO(2023) Contrast Enhanced Magnetic Resonance Imaging of Amyloid-β Plaques in a Murine Alzheimer's Disease Model J Alzheimers Dis, 93(2), 411-419 DOI 10.3233/JAD-220198, PubMed 37038807
Contact information: Group leader Professor Lars Nilsson, Department of Pharmacology University Oslo/Oslo University Hospital, Postboks 1057, Blindern NO-0316 Oslo, Norway. Tel: +47 22840221, E-mail: lars.nilsson@medisin.uio.no